These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3352480)

  • 1. Proton MR properties of lyophilized urine samples from normal and stone former individuals.
    Azoury R; Abrashkin S; Weininger J; Iaina A
    Magn Reson Imaging; 1988; 6(1):49-52. PubMed ID: 3352480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydration properties of urinary compounds obtained from normal and stone former individuals. An NMR study.
    Azoury R; Weininger J; Iaina A; Abrashkin S
    J Urol; 1988 May; 139(5):1111-4. PubMed ID: 3361655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydration feature of urinary compounds. Evidence for molecular abnormality in calcium oxalate urolithiasis.
    Azoury R; Ramon J; Abrashkin S; Shalev J; Goldwasser B
    Urol Res; 1990; 18(1):7-11. PubMed ID: 2316076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto K; Takahara S; Okuyama A
    Eur Urol; 2001 Oct; 40(4):458-62. PubMed ID: 11713403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton MR study of different types of experimental acute renal failure in rats.
    Iaina A; Abrashkin S; Weininger J
    Magn Reson Imaging; 1986; 4(3):241-4. PubMed ID: 3669936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.
    Worcester EM; Coe FL; Evan AP; Parks JH
    BJU Int; 2006 Jun; 97(6):1285-90. PubMed ID: 16686727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
    Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
    Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear magnetic resonance study of an ethyl cellulose sustained-release delivery system. I: Effect of casting solvent on hydration properties.
    Azoury R; Elkayam R; Friedman M
    J Pharm Sci; 1988 May; 77(5):425-7. PubMed ID: 3411466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of drinking water quality on urinary parameters in men with and without urinary tract stones.
    Mirzazadeh M; Nouran MG; Richards KA; Zare M
    Urology; 2012 Mar; 79(3):501-7. PubMed ID: 22173182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal changes in water content and proton magnetic resonance relaxation times in newborn rabbit tissues.
    Berényi E; Szendrö Z; Rózsahegyl P; Bogner P; Sulyok E
    Pediatr Res; 1996 Jun; 39(6):1091-8. PubMed ID: 8725275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary magnesium and its relationship to calcium in recurrent stone-formers and controls (author's transl)].
    Leskovar P; Hartung R; Siebert A; Wellnhofer E
    Urologe A; 1980 Jul; 19(4):214-9. PubMed ID: 7414766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium concentrations in the urine of recurrent stone-formers and their controls (author's transl)].
    Leskovar P; Hartung R; Siebert A; Wellnhofer E
    Urologe A; 1980 Jul; 19(4):207-13. PubMed ID: 7414765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers.
    Kumar V; Peña de la Vega L; Farell G; Lieske JC
    Kidney Int; 2005 Oct; 68(4):1784-92. PubMed ID: 16164655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of MR relaxation properties of pituitary adenomas.
    Pasztor E; Kemeny AA; Tompa K; Furó I; Pócsik I; Fedina L
    J Comput Assist Tomogr; 1987; 11(3):378-83. PubMed ID: 3571577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiexponential proton relaxation processes of compartmentalized water in gels.
    Watanabe T; Murase N; Staemmler M; Gersonde K
    Magn Reson Med; 1992 Sep; 27(1):118-34. PubMed ID: 1279356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.
    Nishiura JL; Campos AH; Boim MA; Heilberg IP; Schor N
    Urol Res; 2004 Oct; 32(5):362-6. PubMed ID: 15221244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of pH on urinary ionized [Ca2+]: differences between urinary tract stone formers and normal subjects.
    Langley SE; Fry CH
    Br J Urol; 1997 Jan; 79(1):8-14. PubMed ID: 9043487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.